Latest Prevalence Rates 2026/27

Latest Prevalence Rates 2026/27

As expected, prevalence rates continue to rise across most disease areas. However, diabetes & NDH is seeing a drop in prevalence (to be confirmed) which could mean the diabetes prevention programme is having an impact. How do your practice prevalence rates compare...
Latest Prevalence Rates 2026/27

Improvement payments for VI001, VI002 & VI003

Additional opportunity based on practice’s making a significant improvement compared to the practices baseline. 2 calculations will apply to the 3 indicators Standard QOF calculation; or Improvement calculation – compares practice’s 2-year baseline, requires an...
QOF 2026/27

QOF 2026/27

    Retired indicators replaced with new indicators – CHD015, CHD016, DM012, HF003, HF006, HYP008, HYP009, NDH002, STIA014, STIA015 Existing register changes – asthma, to include patients from aged 5, COPD to address potential under/over...
GMS Contract/QOF Webinars

GMS Contract/QOF Webinars

Our popular annual QOF webinars are back. Despite there being so many more companies delivering these types of sessions or remain so popular because they are so straight forward – this session will cover the key GMS/QOF updates and prevalence considerations for...
MMRV – VI002  Manual Adjustment for 2025/26

MMRV – VI002 Manual Adjustment for 2025/26

From 1st January 2026 eligible children are now offered a combined MMRV vaccine instead of MMR as part of the childhood routine 2-dose vaccination schedule.  For QOF VI002 , both MMR or MMRV counts towards achievement. However, it was not possible to reflect this...